Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

April 12, 2024

https://www.globenewswire.com/news-release/2024/04/12/2862167/0/en/Mangoceuticals-Subsidiary-MangoRx-Mexico-Executes-Technical-Agreement-with-Mexican-Pharmaceutical-Manufacturer-for-Initial-Development-and-Production-of-its-Mango-Erectile-Dysfunct.html

Signifies the first major step towards the application process for the certification of its
Mango ED oral dissolvable products by Mexico’s health governing agency, COFEPRIS

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.